Latest Adolescent Health News


Biden Administration Moves to Boost Health Care to the Homeless

Biden Administration Moves to Boost Health Care to the HomelessMONDAY, Oct. 16, 2023 (HealthDay News) -- A new rule allows health care providers to be reimbursed for treating homeless people wherever they are, rather than just in hospitals or clinics. The U.S. Centers for Medicare & Medicaid Services (CMS) began allowing this change for both public and private insurers on Oct. 1, KFF Health News reported. “The Biden-Harris administration has been focused on expanding access to health care across the country,” CMS spokesperson Sara Lonardo told KFF Health News, explaining that federal officials created the new reimbursement code at the request of street medicine providers who weren’t being paid for their work. Now doctors, nurses and other providers can provide reimbursed care in a “non-permanent location on the street or found...

Donor's Immune Cells Could Help Transplant Recipients...

16 October 2023
Donor`s Immune Cells Could Help Transplant Recipients Avoid Organ RejectionMONDAY, Oct. 16, 2023 (HealthDay News) -- A liver transplant can give people a new lease on life, but at the cost of lifelong immune-suppressing medication and its risks. Now an innovative approach to reduce, or possibly eliminate, certain patients' reliance on those drugs is showing early promise.The tactic is aimed at priming a transplant recipient's immune system to better tolerate liver tissue from a living donor. A week before the transplant, the recipient receives an infusion of specific immune system cells from the donor -- ones that, in theory, could tone down any immune system attack on the new "foreign" liver.In an early study of 13 patients who received liver tissue from a living donor, researchers found that the approach was safe and feasible.And one year later, the...

Rite Aid Pharmacy Chain Files for Bankruptcy

16 October 2023
Rite Aid Pharmacy Chain Files for BankruptcyMONDAY, Oct. 16, 2023 (HealthDay News) -- The drugstore chain Rite Aid has filed for Chapter 11 bankruptcy, due largely to competition and thousands of lawsuits for its role in allegedly filling unlawful opioid prescriptions.The company filed a notice Thursday with the U.S. Securities and Exchange Commission saying it would not be able to file its latest quarterly financial report before filing for bankruptcy on Sunday, CNN reported Monday.“It was always a matter of when, not if, Rite Aid would file for bankruptcy,” said Neil Saunders, managing director of GlobalData, in a note to investors. “The company has been deep in the red for the past six years.”CVS and Walgreens have suffered, too, the news report notes, as big-box stores like Costco, Target and Walmart emerge as...

Scientists Spot Genes Linked to Raynaud's Phenomenon

16 October 2023
Scientists Spot Genes Linked to Raynaud`s PhenomenonMONDAY, Oct. 16, 2023 (HealthDay News) -- Scientists have discovered two genes that may trigger Raynaud’s phenomenon, a condition that can cause fingers and toes to go cold and numb because of the constriction of tiny blood vessels under the skin.“We identify two distinct genes that point to two distinct mechanisms,” lead researcher Maik Pietzner, chair in health data modeling at Queen Mary University of London’s Precision Healthcare University Research Institute, told NBC News.The condition is triggered by cold temperatures or stress, causing the skin to turn white or blue, then red, according to the Mayo Clinic. People may not be able to move their hands well during an attack, Dr. Marie Gerhard-Herman, an associate professor at Harvard Medical School in Boston, told NBC...

In Study, Diabetes Drug Mounjaro Helped Dieters Shed an Average of 60 Pounds

16 October 2023
In Study, Diabetes Drug Mounjaro Helped Dieters Shed an Average of 60 PoundsMONDAY, Oct. 16, 2023 (HealthDay News) -- A new trial demonstrates the power of the diabetes drug Mounjaro in fighting obesity, helping folks who used the medication lose about 60 pounds."In this study, people who added tirzepatide [Mounjaro] to diet and exercise saw greater, longer-lasting weight reduction than those taking placebo," Dr. Jeff Emmick, senior vice president of product development at drug maker Eli Lilly, said in a company news release. "While intensive lifestyle intervention is an important part of obesity management, these results underscore the difficulty some people face maintaining weight loss with diet and exercise alone."While approved since May 2022 to treat diabetes, Mounjaro has been used “off-label” to treat obesity.Tirzepatide works by targeting two...

Copyright © 2018 HealthDay. All rights reserved.